Martin Lehmann1, Alexander Zarbock1, Jan Rossaint2. 1. Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Gebäude A1, 48149, Münster, Deutschland. 2. Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Gebäude A1, 48149, Münster, Deutschland. rossaint@uni-muenster.de.
Abstract
BACKGROUND: Acutely occurring organ damage significantly contributes to morbidity and mortality in the perioperative context. OBJECTIVE: This article highlights new clinical perspectives on how perioperative organ damage can be prevented and ameliorated by influencing the high mobility group box 1 protein (HMGB1) signaling. MATERIAL AND METHODS: A MEDLINE search was performed in the fields of clinical and basic research. The presentation of basic mechanisms of perioperative organ damage and the discussion of the importance of HMGB1 in prevention and treatment by pharmaceutical and nonpharmaceutical interventions are the focus of the review. RESULTS: The HMGB1 is a central element in the pathogenesis of septic and aseptic inflammation-induced organ damage. Remote ischemic preconditioning (RIPC) and dexmedetomidine are highly effective approaches to mitigate or prevent organ damage. CONCLUSION: The RIPC and dexmedetomidine offer protective properties in ischemia-reperfusion injury as well as in inflammation-related organ damage, which are mediated by HMGB1, among others. This effectively protects the kidneys, heart, lungs, liver and brain. The application of these concepts should be considered in routine clinical practice.
BACKGROUND: Acutely occurring organ damage significantly contributes to morbidity and mortality in the perioperative context. OBJECTIVE: This article highlights new clinical perspectives on how perioperative organ damage can be prevented and ameliorated by influencing the high mobility group box 1 protein (HMGB1) signaling. MATERIAL AND METHODS: A MEDLINE search was performed in the fields of clinical and basic research. The presentation of basic mechanisms of perioperative organ damage and the discussion of the importance of HMGB1 in prevention and treatment by pharmaceutical and nonpharmaceutical interventions are the focus of the review. RESULTS: The HMGB1 is a central element in the pathogenesis of septic and aseptic inflammation-induced organ damage. Remote ischemic preconditioning (RIPC) and dexmedetomidine are highly effective approaches to mitigate or prevent organ damage. CONCLUSION: The RIPC and dexmedetomidine offer protective properties in ischemia-reperfusion injury as well as in inflammation-related organ damage, which are mediated by HMGB1, among others. This effectively protects the kidneys, heart, lungs, liver and brain. The application of these concepts should be considered in routine clinical practice.
Authors: Suzana M Lobo; Ederlon Rezende; Marcos F Knibel; Nilton B Silva; José A Páramo; Flávio E Nácul; Ciro L Mendes; Murilo Assunção; Rubens C Costa; Cíntia C Grion; Sérgio F Pinto; Patricia M Mello; Marcelo O Maia; Péricles A Duarte; Fernando Gutierrez; João M Silva; Marcel R Lopes; José A Cordeiro; Charles Mellot Journal: Anesth Analg Date: 2010-06-08 Impact factor: 5.108
Authors: Alexander Zarbock; Christoph Schmidt; Hugo Van Aken; Carola Wempe; Sven Martens; Peter K Zahn; Britta Wolf; Ulrich Goebel; Christian I Schwer; Peter Rosenberger; Helene Haeberle; Dennis Görlich; John A Kellum; Melanie Meersch Journal: JAMA Date: 2015-06-02 Impact factor: 56.272
Authors: Angela Sauaia; Ernest E Moore; Jeffrey L Johnson; Theresa L Chin; Anirban Banerjee; Jason L Sperry; Ronald V Maier; C Cothren Burlew Journal: J Trauma Acute Care Surg Date: 2014-03 Impact factor: 3.313
Authors: Carolin Torregroza; Chiara O Glashoerster; Katharina Feige; Martin Stroethoff; Annika Raupach; André Heinen; Markus W Hollmann; Ragnar Huhn Journal: Int J Mol Sci Date: 2021-11-19 Impact factor: 5.923